{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:15:07Z","timestamp":1791832507186,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bcp.2021.114425","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T23:22:44Z","timestamp":1611098564000},"page":"114425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Extracellular purines and bone homeostasis"],"prefix":"10.1016","volume":"187","author":[{"given":"Ankita","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas R.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114425_b0005","doi-asserted-by":"crossref","unstructured":"Burnstock, G., Purine and purinergic receptors. Brain Neurosci Adv, 2018. 2: p. 2398212818817494.","DOI":"10.1177\/2398212818817494"},{"key":"10.1016\/j.bcp.2021.114425_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2009.11","article-title":"Long-term (trophic) purinergic signalling: Purinoceptors control cell proliferation, differentiation and death","volume":"1","author":"Burnstock","year":"2010","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bcp.2021.114425_b0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ar.1049","article-title":"From Wolff's law to the Utah paradigm: Insights about bone physiology and its clinical applications","volume":"262","author":"Frost","year":"2001","journal-title":"Anat. Rec."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0020","first-page":"115","article-title":"Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2021.114425_b0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11302-013-9381-4","article-title":"Purinergic signalling in the musculoskeletal system","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bcp.2021.114425_b0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2012.00116","article-title":"Purinergic signalling in bone","volume":"3","author":"Rumney","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.coph.2010.01.003","article-title":"Purinergic signalling and bone remodelling","volume":"10","author":"Orriss","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11302-011-9223-1","article-title":"European meeting \u201cP2 receptors: new targets for the treatment of osteoporosis\u201d","volume":"7","author":"Jorgensen","year":"2011","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bcp.2021.114425_b0045","article-title":"Purinergic signaling in bone","volume":"2013","author":"Jorgensen","year":"2013","journal-title":"J. Osteoporos"},{"key":"10.1016\/j.bcp.2021.114425_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coph.2019.02.013","article-title":"Role of the purinergic P2X receptors in osteoclast pathophysiology","volume":"47","author":"Jorgensen","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114425_b0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2018.03.016","article-title":"The purinergic P2X7 ion channel receptor-a 'repair' receptor in bone","volume":"52","author":"Jorgensen","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2021.114425_b0060","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/0929867321666141215094749","article-title":"The role of P2X receptors in bone biology","volume":"22","author":"Jorgensen","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11302-020-09698-y","article-title":"Innate immunity orchestrates the mobilization and homing of hematopoietic stem\/progenitor cells by engaging purinergic signaling-an update","volume":"16","author":"Ratajczak","year":"2020","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11302-020-09706-1","article-title":"Pannexin-1 channel \u201cfuels\u201d by releasing ATP from bone marrow cells a state of sterile inflammation required for optimal mobilization and homing of hematopoietic stem cells","volume":"16","author":"Cymer","year":"2020","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jbiomech.2011.11.036","article-title":"Application of multiple forms of mechanical loading to human osteoblasts reveals increased ATP release in response to fluid flow in 3D cultures and differential regulation of immediate early genes","volume":"45","author":"Rumney","year":"2012","journal-title":"J. Biomech."},{"issue":"4","key":"10.1016\/j.bcp.2021.114425_b0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11302-016-9526-3","article-title":"c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines","volume":"12","author":"Pacheco-Pantoja","year":"2016","journal-title":"Purinergic Signal"},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1083\/jcb.139.2.497","article-title":"ATP- and gap junction-dependent intercellular calcium signaling in osteoblastic cells","volume":"139","author":"Jorgensen","year":"1997","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114425_b0090","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1359\/jbmr.2000.15.6.1024","article-title":"Human osteoblastic cells propagate intercellular calcium signals by two different mechanisms","volume":"15","author":"Jorgensen","year":"2000","journal-title":"J. Bone Miner Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114425_b0095","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1074\/jbc.M205880200","article-title":"Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells","volume":"278","author":"Jorgensen","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2021.114425_b0100","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1074\/jbc.M104608200","article-title":"Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors","volume":"277","author":"Jorgensen","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114425_b0105","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cellsig.2015.08.016","article-title":"Fine-tuned ATP signals are acute mediators in osteocyte mechanotransduction","volume":"27","author":"Kringelbach","year":"2015","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11302-013-9404-1","article-title":"UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes","volume":"10","author":"Kringelbach","year":"2014","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11302-020-09703-4","article-title":"Adult mesenchymal stem cells: Is there a role for purine receptors in their osteogenic differentiation?","volume":"16","author":"Carluccio","year":"2020","journal-title":"Purinergic Signal"},{"issue":"4","key":"10.1016\/j.bcp.2021.114425_b0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bone.2007.06.011","article-title":"ATP-mediated mineralization of MC3T3-E1 osteoblast cultures","volume":"41","author":"Nakano","year":"2007","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bcp.2021.114425_b0125","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.biocel.2006.05.018","article-title":"Modulation of ERK 1\/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation","volume":"38","author":"Katz","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.abb.2008.06.019","article-title":"Purinergic (ATP) signaling stimulates JNK1 but not JNK2 MAPK in osteoblast-like cells: contribution of intracellular Ca2+ release, stress activated and L-voltage-dependent calcium influx, PKC and Src kinases","volume":"477","author":"Katz","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.abb.2011.06.013","article-title":"Activation of the PI3K\/Akt signaling pathway through P2Y(2) receptors by extracellular ATP is involved in osteoblastic cell proliferation","volume":"513","author":"Katz","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bone.2004.10.016","article-title":"Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: A possible molecular link between mechanical stress and osteoblasts' response","volume":"36","author":"Costessi","year":"2005","journal-title":"Bone"},{"issue":"13","key":"10.1016\/j.bcp.2021.114425_b0145","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.yexcr.2013.05.006","article-title":"ATP and UTP stimulate bone morphogenetic protein-2,-4 and -5 gene expression and mineralization by rat primary osteoblasts involving PI3K\/AKT pathway","volume":"319","author":"Ayala-Pena","year":"2013","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bone.2012.06.013","article-title":"The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors","volume":"51","author":"Orriss","year":"2012","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bcp.2021.114425_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069057","article-title":"Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation","volume":"8","author":"Orriss","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bcp.2021.114425_b0160","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1074\/jbc.M005672200","article-title":"Parathyroid hormone potentiates nucleotide-induced [Ca2+]i release in rat osteoblasts independently of Gq activation or cyclic monophosphate accumulation. A mechanism for localizing systemic responses in bone","volume":"276","author":"Buckley","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2021.114425_b0165","doi-asserted-by":"crossref","first-page":"14315","DOI":"10.1074\/jbc.274.20.14315","volume":"274","author":"Bowler","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114425_b0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cellsig.2018.02.015","article-title":"Extracellular nucleotides enhance agonist potency at the parathyroid hormone 1 receptor","volume":"46","author":"Kim","year":"2018","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/acsptsci.8b00053","article-title":"Toward Defining the Pharmacophore for Positive Allosteric Modulation of PTH1 Receptor Signaling by Extracellular Nucleotides","volume":"2","author":"Kim","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bcp.2021.114425_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115553","article-title":"The role of endogenous GIP and GLP-1 in postprandial bone homeostasis","volume":"140","author":"Helsted","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2021.114425_b0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4939-3566-6_7","article-title":"Assessing extracellular ATP as danger Signal In Vivo: The pmeLuc System","volume":"1417","author":"Di Virgilio","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2021.114425_b0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4939-9717-6_13","article-title":"Detection of Extracellular ATP in the Tumor Microenvironment, Using the pmeLUC Biosensor","volume":"2041","author":"De Marchi","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0195","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bjp.0700961","article-title":"Effects of extracellular nucleotides on single cells and populations of human osteoblasts: Contribution of cell heterogeneity to relative potencies","volume":"120","author":"Dixon","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0200","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bone.2006.02.063","article-title":"Osteoblast responses to nucleotides increase during differentiation","volume":"39","author":"Orriss","year":"2006","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bcp.2021.114425_b0205","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jbmr.5650060707","article-title":"Purinergic regulation of cytosolic calcium and phosphoinositide metabolism in rat osteoblast-like osteosarcoma cells","volume":"6","author":"Kumagai","year":"1991","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jbmr.5650070504","article-title":"Evidence for P2-purinoceptors on human osteoblast-like cells","volume":"7","author":"Schofl","year":"1992","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0215","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JME-14-0226","article-title":"P2X7 receptors: Role in bone cell formation and function","volume":"54","author":"Agrawal","year":"2015","journal-title":"J. Mol. Endocrinol."},{"issue":"2\u20134","key":"10.1016\/j.bcp.2021.114425_b0220","first-page":"243","article-title":"Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice","volume":"13","author":"Gartland","year":"2003","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.bcp.2021.114425_b0225","article-title":"Genetic background strongly influences the bone phenotype of P2X7 Receptor Knockout Mice","volume":"2012","author":"Syberg","year":"2012","journal-title":"J. Osteoporos"},{"issue":"7","key":"10.1016\/j.bcp.2021.114425_b0230","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1210\/me.2003-0021","article-title":"Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption","volume":"17","author":"Ke","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00223-009-9237-7","article-title":"P2X7 nucleotide receptor plays an important role in callus remodeling during fracture repair","volume":"84","author":"Li","year":"2009","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"10.1016\/j.bcp.2021.114425_b0240","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1038\/s41598-018-21574-9","article-title":"P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2021.114425_b0245","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/jcp.23001","article-title":"CD73-generated adenosine promotes osteoblast differentiation","volume":"227","author":"Takedachi","year":"2012","journal-title":"J. Cell Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tice.2017.07.001","article-title":"Ecto-5'-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging mice","volume":"49","author":"Bradaschia-Correa","year":"2017","journal-title":"Tissue Cell"},{"issue":"4","key":"10.1016\/j.bcp.2021.114425_b0255","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1096\/fj.10-169854","article-title":"P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration","volume":"25","author":"Pellegatti","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2021.114425_b0260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bone.2014.09.016","article-title":"Mineralisation of collagen rich soft tissues and osteocyte lacunae in Enpp1(-\/-) mice","volume":"69","author":"Hajjawi","year":"2014","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0265","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S8756-3282(01)00430-6","article-title":"Extracellular nucleotide signaling: A mechanism for integrating local and systemic responses in the activation of bone remodeling","volume":"28","author":"Bowler","year":"2001","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bcp.2021.114425_b0270","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/jbmr.2740","article-title":"Pannexin-1 and P2X7-receptor are required for apoptotic osteocytes in fatigued bone to Trigger RANKL production in neighboring bystander osteocytes","volume":"31","author":"Cheung","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114425_b0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11302-016-9495-6","article-title":"Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury","volume":"12","author":"Varley","year":"2016","journal-title":"Purinergic Signal"},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0280","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ejhg.2011.245","article-title":"Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women","volume":"20","author":"Gartland","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0285","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00198-012-2035-5","article-title":"Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis","volume":"24","author":"Husted","year":"2013","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.bcp.2021.114425_b0290","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ejhg.2011.253","article-title":"Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures","volume":"20","author":"Jorgensen","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2021.114425_b0295","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00198-012-2059-x","article-title":"Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients","volume":"24","author":"Wesselius","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.bcp.2021.114425_b0300","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 purinergic signalling in the tumour microenvironment","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2021.114425_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002599","article-title":"Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase","volume":"3","author":"Pellegatti","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/onc.2016.206","article-title":"Extracellular purines, purinergic receptors and tumor growth","volume":"36","author":"Di Virgilio","year":"2017","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bcp.2021.114425_b0315","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2174\/0929867321666141012172913","article-title":"Emerging roles of P2X receptors in cancer","volume":"22","author":"Adinolfi","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114425_b0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coph.2016.05.001","article-title":"P2 receptors in cancer progression and metastatic spreading","volume":"29","author":"Di Virgilio","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114425_b0325","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fimmu.2017.01526","article-title":"Multifaceted effects of extracellular adenosine triphosphate and adenosine in the tumor-host interaction and therapeutic perspectives","volume":"8","author":"de Andrade Mello","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2021.114425_b0330","article-title":"P2X7 receptor function in bone-related cancer","volume":"2012","author":"Adinolfi","year":"2012","journal-title":"J. Osteoporos"},{"issue":"12","key":"10.1016\/j.bcp.2021.114425_b0335","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","article-title":"Expression of P2X7 receptor increases in vivo tumor growth","volume":"72","author":"Adinolfi","year":"2012","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114425_b0340","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood-2015-10-646810","article-title":"Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma","volume":"127","author":"van de Donk","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2021.114425_b0345","article-title":"Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma","volume":"5","author":"Rizzieri","year":"2019","journal-title":"J. Cancer Metastasis Treat"},{"key":"10.1016\/j.bcp.2021.114425_b0350","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2119\/molmed.2016.00198","article-title":"Adenosine generated in the bone marrow niche through a CD38-mediated pathway correlates with progression of human myeloma","volume":"22","author":"Horenstein","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2021.114425_b0355","doi-asserted-by":"crossref","unstructured":"Yang, R., et al., Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. J Immunother Cancer, 2020. 8(1).","DOI":"10.1136\/jitc-2020-000610"},{"key":"10.1016\/j.bcp.2021.114425_b0360","doi-asserted-by":"crossref","unstructured":"Morandi, F., et al., Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD. Oncoimmunology, 2018. 7(8): p. e1458809.","DOI":"10.1080\/2162402X.2018.1458809"},{"issue":"8","key":"10.1016\/j.bcp.2021.114425_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136080","article-title":"Multidrug resistance-associated protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in colorectal cancer cells and enhances their survival to chemotherapeutic drugs","volume":"10","author":"Vinette","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bcp.2021.114425_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112341","article-title":"Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts","volume":"9","author":"Agrawal","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bcp.2021.114425_b0375","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1216292","article-title":"Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment","volume":"5","author":"Antonioli","year":"2016","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.bcp.2021.114425_b0380","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4049\/jimmunol.151.1.526","article-title":"Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis","volume":"151","author":"Wolos","year":"1993","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114425_b0385","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2021.114425_b0390","series-title":"A basis for distinguishing two types of purinergic receptor, in Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach","first-page":"107","author":"Burnstock","year":"1978"},{"key":"10.1016\/j.bcp.2021.114425_b0395","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2741\/208","article-title":"Bone phenotypes of P2 receptor knockout mice","volume":"3","author":"Orriss","year":"2011","journal-title":"Front Biosci. (Schol Ed)"},{"issue":"9","key":"10.1016\/j.bcp.2021.114425_b0400","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1210\/en.2007-0066","article-title":"Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate","volume":"148","author":"Orriss","year":"2007","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.bcp.2021.114425_b0405","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1210\/en.2011-1073","article-title":"The P2Y(6) receptor stimulates bone resorption by osteoclasts","volume":"152","author":"Orriss","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2021.114425_b0410","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/me.2011-1083","article-title":"Reduced bone turnover in mice lacking the P2Y13 receptor of ADP","volume":"26","author":"Wang","year":"2012","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0415","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1096\/fj.13-243626","article-title":"The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development","volume":"28","author":"Wang","year":"2014","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.bcp.2021.114425_b0420","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/jbmr.1877","article-title":"The P2Y13 receptor regulates extracellular ATP metabolism and the osteogenic response to mechanical loading","volume":"28","author":"Wang","year":"2013","journal-title":"J. Bone Miner Res."},{"issue":"12","key":"10.1016\/j.bcp.2021.114425_b0425","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/stem.1411","article-title":"Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes","volume":"31","author":"Biver","year":"2013","journal-title":"Stem. Cells"},{"issue":"1","key":"10.1016\/j.bcp.2021.114425_b0430","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41598-017-00139-2","article-title":"The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"52","key":"10.1016\/j.bcp.2021.114425_b0435","doi-asserted-by":"crossref","first-page":"42952","DOI":"10.1074\/jbc.M506415200","article-title":"The P2X7 nucleotide receptor mediates skeletal mechanotransduction","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2021.114425_b0440","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1083\/jcb.200708037","article-title":"P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: A signaling axis promoting osteogenesis","volume":"181","author":"Panupinthu","year":"2008","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0445","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11302-016-9546-z","article-title":"Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice","volume":"13","author":"Metzger","year":"2017","journal-title":"Purinergic Signal"},{"issue":"7","key":"10.1016\/j.bcp.2021.114425_b0450","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1096\/fj.09-147447","article-title":"Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function","volume":"24","author":"Kara","year":"2010","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0455","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/art.27219","article-title":"Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice","volume":"62","author":"Kara","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0460","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11302-012-9292-9","article-title":"Adenosine A1 receptor regulates osteoclast formation by altering TRAF6\/TAK1 signaling","volume":"8","author":"He","year":"2012","journal-title":"Purinergic Signal"},{"issue":"2","key":"10.1016\/j.bcp.2021.114425_b0465","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ajpath.2011.10.017","article-title":"Adenosine A(2A) receptor ligation inhibits osteoclast formation","volume":"180","author":"Mediero","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114425_b0470","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1074\/jbc.M112.344994","article-title":"A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo","volume":"287","author":"Carroll","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:19:01Z","timestamp":1757769541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":94,"alternative-id":["S0006295221000216"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114425","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular purines and bone homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114425"}}